Triple-negative breast cancer (TNBC) is a subtype of BC distinguished by the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) in tumor cells (19). Here, ESR1 is linked to triple-negative breast carcinoma.